Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 39.34%55.31K | 39.7K | -62.05%50.12K | -24.04%132.06K | 141.54%173.86K | -41.97%71.98K | -6.93%124.03K | -52.75%133.26K | 171.90%282.01K | |
| Other cash income from operating activities | 39.34%55.31K | --39.7K | ---- | -62.05%50.12K | -24.04%132.06K | 141.54%173.86K | -41.97%71.98K | -6.93%124.03K | -52.75%133.26K | 171.90%282.01K |
| Cash paid | 0.82%-329.2K | 20.80%-331.91K | -22.73%-419.11K | 1.01%-341.5K | -21.16%-344.99K | -52.93%-284.74K | 0.52%-186.2K | 30.44%-187.17K | 56.50%-269.08K | -14.36%-618.62K |
| Payments to suppliers for goods and services | 0.82%-329.2K | 20.80%-331.91K | -22.73%-419.11K | 1.01%-341.5K | -21.16%-344.99K | -52.93%-284.74K | 0.52%-186.2K | 30.44%-187.17K | 56.50%-269.08K | -14.36%-618.62K |
| Direct interest received | 262.54%20.24K | 4,034.81%5.58K | 136.84%135 | -50.43%57 | -96.18%115 | -26.61%3.01K | 1,044.01%4.11K | -72.21%359 | -97.74%1.29K | 799.89%57.25K |
| Operating cash flow | 11.51%-253.65K | 31.59%-286.64K | -43.82%-418.97K | -36.89%-291.33K | -97.29%-212.82K | 2.03%-107.87K | -75.38%-110.11K | 53.33%-62.78K | 51.84%-134.53K | 35.16%-279.36K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 165.13%194.76K | 81.37%-299.06K | -225.90%-1.61M | -45.95%-492.56K | -32.97%-337.48K | -1,400.50%-253.81K | 96.18%-16.92K | -828.95%-442.97K | 109.96%60.77K | -49.52%-610.13K |
| Capital expenditure reported | -3.55%-377.19K | 76.27%-364.25K | -153.43%-1.54M | -100.89%-605.75K | 18.81%-301.54K | -82.87%-371.39K | 64.64%-203.09K | -62.30%-574.34K | 74.50%-353.87K | -174.61%-1.39M |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---35.95K | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | 777.34%571.96K | 193.00%65.19K | -161.93%-70.1K | --113.19K | ---- | -36.84%117.58K | 41.71%186.17K | -68.32%131.37K | -46.67%414.63K | 699.38%777.53K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 165.13%194.76K | 81.37%-299.06K | -225.90%-1.61M | -45.95%-492.56K | -32.97%-337.48K | -1,400.50%-253.81K | 96.18%-16.92K | -828.95%-442.97K | 109.96%60.77K | -49.52%-610.13K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,354.72%456.8K | -101.45%-14.04K | 357.31%970K | -92.46%212.11K | 12,467.11%2.81M | -102.95%-22.75K | 18,650.19%770.63K | -98.98%4.11K | -63.93%404.78K | 1.12M |
| Net common stock issuance | 3,354.72%456.8K | -101.45%-14.04K | 357.31%970K | -92.46%212.11K | 12,467.11%2.81M | -102.95%-22.75K | 18,650.19%770.63K | -98.98%4.11K | -63.93%404.78K | --1.12M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,354.72%456.8K | -101.45%-14.04K | 357.31%970K | -92.46%212.11K | 12,467.11%2.81M | -102.95%-22.75K | 18,650.19%770.63K | -98.98%4.11K | -63.93%404.78K | --1.12M |
| Net cash flow | ||||||||||
| Beginning cash position | -58.82%419.84K | -50.84%1.02M | -21.61%2.07M | 592.57%2.65M | -50.16%381.99K | 524.03%766.43K | -80.33%122.82K | 112.80%624.46K | 383.22%293.44K | -93.25%60.73K |
| Current changes in cash | 166.35%397.91K | 43.11%-599.73K | -84.38%-1.05M | -125.26%-571.78K | 688.81%2.26M | -159.73%-384.44K | 228.30%643.61K | -251.55%-501.64K | 42.24%331.02K | 127.74%232.72K |
| End cash Position | 94.78%817.75K | -58.82%419.84K | -50.84%1.02M | -21.61%2.07M | 592.57%2.65M | -50.16%381.99K | 524.03%766.43K | -80.33%122.82K | 112.80%624.46K | 383.22%293.44K |
| Free cash from | 3.08%-630.84K | 66.69%-650.89K | -117.83%-1.95M | -63.01%-897.07K | -14.82%-550.31K | -53.02%-479.26K | 50.84%-313.2K | -30.45%-637.12K | 70.70%-488.4K | -78.07%-1.67M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |